Resources
About Us
Home Report
Store
Autoinjectors Market
Autoinjectors Market Size, Share, Forecast, & Trends Analysis by Type (Disposable, Reusable, Wearable), Technology (Manual, Automatic), Application (Arthritis, Diabetes, Osteoporosis), Distribution, Route of Administration, End User – Global Forecast to 2031
Report ID:MRHC - 1041216 Pages: 230 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Autoinjectors Market was valued at $2.01 billion in 2023. This market is expected to reach $3.76 billion by 2031, from an estimated $2.16 billion in 2024, at a CAGR of 8.3% during the forecast period 2024-2031.
Autoinjectors Market Size & Forecast
The growth of this market is primarily driven by the increasing prevalence of chronic & autoimmune diseases, the growing demand for self-administration of medicines, and technological advancements in autoinjectors. Moreover, the growing demand for home healthcare and partnerships & collaborations by market players are expected to generate market growth opportunities.
Autoinjectors Market Growth Drivers
Increasing Prevalence of Chronic & Autoimmune Diseases
Autoinjectors are utilized to treat various chronic diseases, including diabetes, osteoporosis, and rheumatoid arthritis, as well as autoimmune diseases and adverse occurrences. For instance:
- According to the International Diabetes Federation, in 2021, 537 million people were diagnosed with diabetes worldwide. Among these, the Western Pacific region accounted for 206 million cases, while Southeast Asia accounted for 90 million, the Middle East & North Africa for 73 million, Europe for 61 million, North America & the Caribbean for 51 million, South and Central America for 32 million, and Africa for 24 million. This number is projected to reach 643 million in 2030 and 783 million in 2045.
- According to the World Health Organization’s (WHO) 2023 data, 18 million people had rheumatoid arthritis in 2019.
- According to a 2023 survey conducted by the International Osteoporosis Foundation (IDF), 43% of women respondents reported having fractured a bone after a simple fall and bump after the age of 50. The percentages were the highest in Japan (73.3%) and the U.K. (60.9%) and lowest in Brazil (21.6%).
Thus, the increasing incidence of chronic & autoimmune diseases is boosting the demand for autoinjectors for proper medication.
Click here to: Get a Free Sample Copy of this Report
Technological Advancements in Autoinjectors
Advancements in autoinjector technology have improved their safety and reliability. Advanced autoinjectors include features that maintain proper dosage precision and avoid accidental needlestick injuries. For instance, needle-retraction systems withdraw the needle after injection to reduce needlestick injuries. Autoinjectors have progressively become more user-friendly. Companies have invested in design innovation to simplify the distribution and use of autoinjectors. These devices are lightweight, small, and have simple mechanics that allow patients to self-administer medication with minimal discomfort and effort.
Moreover, many autoinjectors now have connectivity features that allow them to communicate with smartphones and other devices. This connectivity allows for the gathering of information about injection history, medicine use, and patient adherence. These technological advances in autoinjector performance and design have enhanced treatment adherence, patient experience, and overall safety, driving the adoption of autoinjectors.
Autoinjectors Market Opportunities
Partnerships & Collaborations by Market Players
Market players are focusing on partnerships and collaborations due to the increasing demand for autoinjectors. New and advanced products are being introduced into the market to reduce needle phobia and improve patient compliance. For instance:
-
In January 2024, FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (U.S.) partnered with SHL Medical AG (Switzerland) to cater to the growing market demand for autoinjectors.
- In May 2023, MoonLake Immunotherapeutics AG (Switzerland) collaborated with SHL Medical AG (Switzerland) to develop an autoinjector for the commercial and clinical supply of MoonLake’s Nanobody Sonelokimab.
- In May 2022, Stevanato Group S.p.A. (Italy) partnered with Owen Mumford Limited (U.K) for its Aidaptus autoinjector.
- In November 2021, Gerresheimer AG (Germany) partnered with Midas Pharma GmbH (Germany) to market and develop a new-generation autoinjector.
Thus, increasing partnerships & collaborations by market players are generating opportunities for market expansion.
Growing Demand for Home Healthcare
Self-administration enables patients by allowing them to actively participate in their medical treatment. It reduces the need for frequent visits to medical centers for medicine delivery, easing the strain on both doctors and patients. Autoinjectors are portable and simple to use, which makes them ideal for patients to carry and self-administer medication as needed.
People develop various chronic diseases as they age, necessitating drug management. Autoinjectors make drug administration easier for older adults who have limited physical acuity. The ease of use and simplicity provided by autoinjectors make them an appealing option for this age group. According to a report published by the Joint Center for Housing Studies at Harvard University, by 2035, one in every three American households will be headed by individuals aged 65 or older. Thus, high hospitalization costs, the growing aging population, and the rising need for personal medical care are driving the demand for home healthcare services and autoinjectors.
Autoinjectors Market Trends
Smart/Electronic Autoinjectors
Smart/electronic autoinjectors use Wi-Fi, Bluetooth, and mobile apps to communicate with smartphones and other devices. This interaction allows for data analysis, collection, and exchange. Patients get reminders for medication and information on injection history and can share information with doctors to improve treatment management. Telemedicine and digital health systems can be coupled with smart autoinjectors to enhance remote monitoring.
Smart autoinjectors offer benefits such as dose customization and personalization, real-time guidance, and improved medication and treatment outcomes. Furthermore, various companies are focusing on launching smart autoinjectors. For instance, in May 2021, Phillips-Medisize (U.S.) launched the Aria Smart Autoinjector platform to unlock differentiation and sustainability in the digital drug-delivery devices market.
Autoinjectors Market Analysis: Key Findings
By Type: The Disposable Autoinjectors Segment to Dominate the Autoinjectors Market in 2024
Based on type, the autoinjectors market is segmented into disposable autoinjectors, reusable autoinjectors, smart autoinjectors, and wearable autoinjectors. In 2024, the disposable autoinjectors segment is expected to account for the largest share of 51.7% of the autoinjectors market. The large market share of this segment can be attributed to the advantages of disposable autoinjectors over other types, such as automatic safety features, ease of use (especially for patients with low dexterity), audible and visual feedback indicators, consistent injection activation, complete injection, and controlled injection depth. Furthermore, the companies operating in this market are focused on introducing innovative offerings to cater to the rising demand for autoinjectors. For instance, in January 2024, Taisho Pharmaceutical Co., Ltd. (Japan) launched the Nanozora 30mg Autoinjector for S.C. Injection, a single-use autoinjector dosage form, to prevent needle piercing accidents. Such developments are contributing to the segment’s large share.
However, the smart autoinjectors segment is projected to register the highest CAGR of 9.7% during the forecast period 2024-2031. The growth of this segment is driven by technological advancements in autoinjectors and the benefits of smart autoinjectors, such as dosage accuracy through prefilled medication, reduced anxiety due to minimal needle injuries, and improved patient compliance and medication adherence.
By Route of Administration: The Subcutaneous Segment to Dominate the Autoinjectors Market in 2024
Based on route of administration, the autoinjectors market is segmented into subcutaneous and intramuscular. In 2024, the subcutaneous segment is expected to account for the larger share of the autoinjectors market. The segment’s large market share can be attributed to the availability of a large number of drugs that are administered subcutaneously, and the increasing number of new drugs being launched for subcutaneous self-administration. For instance, in May 2022, Jabil, Inc. (U.S.) launched Qfinity, a modular solution for subcutaneous (SC) drug self-administration and a reusable autoinjector platform, to support drug delivery in the pharmaceutical industry. Such developments are expected to support the growth of this segment in the coming years.
By Technology: The Manual Autoinjectors Segment to Dominate the Autoinjectors Market in 2024
Based on technology, the autoinjectors market is segmented into manual autoinjectors and automatic autoinjectors. In 2024, the manual autoinjectors segment is expected to account for the larger share of the autoinjectors market. The segment’s large market share can be attributed to the increasing adoption of manual autoinjectors due to their lower prices compared to automatic injectors, ease of use, and ability to provide controlled and precise dosing.
By Application: The Diabetes Segment to Dominate the Autoinjectors Market in 2024
Based on application, the autoinjectors market is segmented into rheumatoid arthritis, osteoporosis, diabetes, multiple sclerosis, and other applications. In 2024, the diabetes segment is expected to account for the largest share of the autoinjectors market. The segment’s large market share can be attributed to the increasing number of insulin-dependent patients and the rising number of diabetes cases. For instance, according to the International Diabetes Federation, 537 million people were diagnosed with diabetes globally in 2021. This number is expected to increase to 783 million in 2045. Thus, the increasing number of diabetes cases contributes to the segment’s large market share.
By Distribution Channel: The Retail Pharmacies Segment to Dominate the Autoinjectors Market in 2024
Based on distribution channel, the autoinjectors market is segmented into hospital pharmacies, retail pharmacies, and online/e-commerce platforms. In 2024, the retail pharmacies segment is expected to account for the largest share of the autoinjectors market. The large market share of this segment can be attributed to the availability of a diverse selection of autoinjectors at retail pharmacies, which enables patients to choose the most suitable autoinjector based on their specific preferences, needs, and healthcare expert recommendations. The wide variety of autoinjector options available at retail pharmacies ensures that patients can purchase autoinjectors that best suit their needs.
By End User: The Home Care Segment to Dominate the Autoinjectors Market in 2024
Based on end user, the autoinjectors market is segmented into home care, hospitals & clinics, and other end users. In 2024, the home care segment is expected to account for the largest share of 57.6% of the autoinjectors market. The large market share of this segment can be attributed to the increasing adoption of home care devices due to their convenience, precision, and accuracy. Additionally, market players have increased their focus on raising awareness about diseases such as diabetes and rheumatoid arthritis, driving the adoption of autoinjectors in home care settings.
Furthermore, this segment is also projected to register the highest CAGR of 8.8% during the forecast period 2024-2031. Patients’ increasing preference for the self-administration of medications and technological advancements in autoinjectors are driving the growth of this segment.
Geographic Analysis
By Geography: North America to Dominate the Autoinjectors Market in 2024
In 2024, North America is expected to account for the largest share of 36.5% of the autoinjectors market, followed by Europe and Asia-Pacific. North America’s significant market share can be primarily attributed to the presence of major autoinjector manufacturers such as Halozyme, Inc. (U.S.) and Becton, Dickinson and Company (U.S.), the increasing demand for self-administration of drugs, technological advancements in autoinjectors, and the increasing cases of diabetes, osteoporosis, and rheumatoid arthritis in the region.
However, Asia-Pacific is slated to register the highest CAGR of 8.8% during the forecast period. The growth of this regional market is driven by the growing awareness about autoinjectors, the increasing number of awareness programs focusing on autoimmune diseases in countries such as China and India, and the growing healthcare infrastructure in the region.
Autoinjectors Market: Key Companies
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted in the last 3–4 years. Some of the key players operating in the autoinjectors market are Becton, Dickinson and Company (U.S.), Ypsomed AG (Switzerland), SHL Medical (Switzerland), Recipharm AB (Sweden), Owen Mumford Limited (U.K), Halozyme, Inc. (U.S.), AstraZeneca (U.K.), Teva Pharmaceutical Industries Ltd. (Israel), Solteam Incorporation Co., Ltd. (China), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Bayer AG (Germany), and Union Medico ApS. (Denmark).
Autoinjectors Industry Overview: Latest Developments from Key Industry Players
-
In October 2023, ALTAVIZ (U.S.) launched AltaVISC, a new autoinjector platform for next-generation therapies.
-
In May 2023, Coherus BioSciences, Inc. (U.S.) launched the UDENYCA (pegfilgrastim-cbqv), single-dose (6mg/0.6mL), prefilled autoinjector to decrease the incidence of infection as displayed by febrile neutropenia.
- In May 2023, C.H. Boehringer Sohn AG & Co. KG (Germany) received the U.S. Food and Drug Administration (FDA) approval for its Cyltezo Pen, a new autoinjector option for Cyltezo (adalimumab-adbm) to treat multiple chronic inflammatory diseases.
- In April 2020, Teva Pharmaceuticals USA, Inc. (U.S.) launched an autoinjector device for the AJOVY (fremanezumab-vfrm) injection for the preventive treatment of migraine in adults in the U.S.
Autoinjectors Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
230 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR (Value) |
8.3% |
|
Market Size (Value) |
$3.76 Billion by 2031 |
|
Segments Covered |
By Type
By Route of Administration
By Technology
By Application
By Distribution Channel
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, Italy, U.K., Spain, Austria, Netherlands, and Rest of Europe), Asia–Pacific (India, China, Japan, Australia, South Korea, and Rest of Asia–Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. |
|
Key Companies Profiled |
Becton, Dickinson and Company (U.S.), Ypsomed AG (Switzerland), SHL Medical (Switzerland), Recipharm AB (Sweden), Owen Mumford Limited (U.K), Halozyme, Inc. (U.S.), AstraZeneca (U.K.), Teva Pharmaceutical Industries Ltd. (Israel), Solteam Incorporation Co., Ltd. (China), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Bayer AG (Germany), and Union Medico ApS. (Denmark). |
Key questions answered in the autoinjectors market report:
The Autoinjectors Market comprises devices designed for the self-administration of drugs, typically for chronic conditions like diabetes, rheumatoid arthritis, and other autoimmune diseases. These devices enhance convenience and safety, allowing patients to administer precise doses of medications with minimal effort.
The market size is projected to be $2.16 billion in 2024, and it is expected to grow to $3.76 billion by 2031.
The market is projected to grow to $3.76 billion by 2031, from an estimated $2.16 billion in 2024, at a CAGR of 8.3% during the forecast period from 2024 to 2031.
The market size is projected to be $2.16 billion in 2024, and it is expected to grow to $3.76 billion by 2031.
Key players in the market include Becton, Dickinson and Company (U.S.), SHL Medical (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), AstraZeneca (U.K.), Gerresheimer AG (Germany), Halozyme, Inc. (U.S.), Owen Mumford Limited (U.K.), and Ypsomed AG (Switzerland).
The key trends in the market include the rise of smart/electronic autoinjectors with connectivity features like Bluetooth and Wi-Fi, increasing focus on self-administration, and technological advancements that improve ease of use, safety, and patient compliance.
The major drivers include the increasing prevalence of chronic and autoimmune diseases, growing demand for self-administration of medications, advancements in autoinjector technology, and the rising demand for home healthcare solutions.
The market is segmented by:
- Type: Disposable autoinjectors, reusable autoinjectors, smart autoinjectors, and wearable autoinjectors.
- Route of Administration: Subcutaneous and intramuscular.
- Technology: Manual and automatic autoinjectors.
- Application: Rheumatoid arthritis, osteoporosis, diabetes, multiple sclerosis, and other applications.
The global outlook is positive, with strong growth anticipated in all major regions, particularly in North America and Asia-Pacific. North America is expected to dominate the market due to the high adoption of self-administration technologies, while Asia-Pacific is expected to grow at the highest rate.
The market is projected to grow at a CAGR of 8.3% from 2024 to 2031, driven by increasing healthcare needs, the growing incidence of chronic diseases, and technological advancements.
The market is expected to grow at a CAGR of 8.3% from 2024 to 2031.
North America is expected to hold the largest market share, accounting for 36.5% of the Autoinjectors Market in 2024, followed by Europe and Asia-Pacific. However, Asia-Pacific is projected to grow at the fastest rate during the forecast period.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation Process
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing & Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Chronic & Autoimmune Diseases
4.2.2. Growing Demand for Self-administration
4.2.3. Technological Advancements in Autoinjectors
4.3. Restraints
4.3.1. Availability of Alternatives to Autoinjectors
4.3.2. High Costs of Autoinjectors
4.3.3. Needlestick Injury Concerns
4.4. Opportunities
4.4.1. Growing Demand for Home Healthcare
4.4.2. Partnerships & Collaborations by Market Players
4.5. Challenges
4.5.1. Limited Access to Healthcare in Developing Countries
4.5.2. Lack of Knowledge and Awareness Regarding Autoinjector Usage in Emerging Economies
4.6. Trends
4.6.1. Smart/Electronic Autoinjectors
4.6.2. Increasing Adoption of Wearable Devices
4.7. Factor Analysis
4.8. Regulatory Analysis
4.8.1. U.S.
4.8.2. Canada
4.8.3. Europe
4.8.4. China
4.8.5. Japan
4.8.6. India
4.8.7. Latin America
4.8.8. Middle East
4.9. Pricing Analysis
4.10. Parent/Adjacent Market Analysis
4.11. Porter’s Five Forces Analysis
5. Autoinjectors Market Assessment—by Type
5.1. Overview
5.2. Disposable Autoinjectors
5.3. Reusable Autoinjectors
5.4. Smart Autoinjectors
5.4.1. Bluetooth Connectivity
5.4.2. Near Field Communication (NFC) Connectivity
5.5. Wearable Autoinjectors
6. Autoinjectors Market Assessment—by Route of Administration
6.1. Overview
6.2. Subcutaneous
6.3. Intramuscular
7. Autoinjectors Market Assessment—by Technology
7.1. Overview
7.2. Manual
7.3. Automatic
8. Autoinjectors Market Assessment—by Application
8.1. Overview
8.2. Rheumatoid Arthritis
8.3. Osteoporosis
8.4. Diabetes
8.5. Multiple Sclerosis
8.6. Other Applications
9. Autoinjectors Market Assessment—by Distribution Channel
9.1. Overview
9.2. Hospital Pharmacies
9.3. Retail Pharmacies
9.4. Online/E-commerce Platforms
10. Autoinjectors Market Assessment—by End User
10.1. Overview
10.2. Home Care
10.3. Hospitals & Clinics
10.4. Other End Users
11. Autoinjectors Market Assessment—by Geography
11.1. Overview
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Austria
11.3.7. Netherlands
11.3.8. Rest of Europe
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia
11.4.5. South Korea
11.4.6. Rest of Asia-Pacific
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Rest of Latin America
11.6. Middle East & Africa
12. Competition Analysis
12.1. Overview
12.2. Key Growth Strategies
12.3. Competitive Benchmarking
12.4. Competitive Dashboard
12.4.1. Industry Leaders
12.4.2. Market Differentiators
12.4.3. Vanguards
12.4.4. Emerging Companies
12.5. Market Share Analysis/Market Rankings of Key Players (2023)
13. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
13.1. Novo Nordisk A/S
13.2. Eli Lilly and Company
13.3. Sanofi S.A.
13.4. Biocon Limited
13.5. Becton, Dickinson and Company
13.6. Ypsomed AG
13.7. Owen Mumford Limited
13.8. Medtronic plc
13.9. Emperra GmbH E-Health Technologies
13.10. pendiq GmbH
13.11. Jiangsu Delfu medical device Co., Ltd
(Note: SWOT analysis will be provided for the top 5 companies.)
14. Appendix
14.1. Available Customization
14.2. Related Reports
List of Tables
Table 1 Global Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 2 Global Disposable Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Reusable Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 5 Global Smart Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Bluetooth-connected Smart Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Near Field Communication (NFC)-connected Smart Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Wearable Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 10 Global Subcutaneous Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Intramuscular Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 13 Global Manual Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Automatic Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 16 Global Autoinjectors Market for Rheumatoid Arthritis, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Autoinjectors Market for Osteoporosis, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Autoinjectors Market for Diabetes, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Autoinjectors Market for Multiple Sclerosis, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Autoinjectors Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 22 Global Autoinjectors Market for Hospital Pharmacies, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Autoinjectors Market for Retail Pharmacies, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Autoinjectors Market for Online/E-commerce Platforms, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 26 Global Autoinjectors Market for Home Care, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Autoinjectors Market for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Autoinjectors Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 30 North America: Autoinjectors Market, by Country, 2022–2031 (USD Million)
Table 31 North America: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 32 North America: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 33 North America: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 34 North America: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 35 North America: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 36 North America: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 37 North America: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 38 U.S.: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 39 U.S.: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 40 U.S.: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 41 U.S.: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 42 U.S.: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 43 U.S.: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 44 U.S.: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 45 Canada: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 46 Canada: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 47 Canada: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 48 Canada: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 49 Canada: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 50 Canada: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 51 Canada: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 52 Europe: Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 53 Europe: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 54 Europe: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 55 Europe: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 56 Europe: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 57 Europe: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 58 Europe: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 59 Europe: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 60 Germany: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 61 Germany: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 62 Germany: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 63 Germany: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 64 Germany: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 65 Germany: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 66 Germany: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 67 France: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 68 France: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 69 France: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 70 France: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 71 France: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 72 France: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 73 France: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 74 Italy: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 75 Italy: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 76 Italy: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 77 Italy: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 78 Italy: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 79 Italy: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 80 Italy: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 81 Spain: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 82 Spain: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 83 Spain: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 84 Spain: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 85 Spain: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 86 Spain: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 87 Spain: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 88 U.K.: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 89 U.K.: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 90 U.K.: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 91 U.K.: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 92 U.K.: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 93 U.K.: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 94 U.K.: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 95 Austria: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 96 Austria: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 97 Austria: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 98 Austria: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 99 Austria: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 100 Austria: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 101 Austria: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 102 Netherlands: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 103 Netherlands: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 104 Netherlands: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 105 Netherlands: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 106 Netherlands: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 107 Netherlands: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 108 Netherlands: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 109 Rest of Europe: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 110 Rest of Europe: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 111 Rest of Europe: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 112 Rest of Europe: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 113 Rest of Europe: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 114 Rest of Europe: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 115 Rest of Europe: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 116 Asia-Pacific: Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 117 Asia-Pacific: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 118 Asia-Pacific: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 119 Asia-Pacific: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 120 Asia-Pacific: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 121 Asia-Pacific: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 122 Asia-Pacific: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 123 Asia-Pacific: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 124 China: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 125 China: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 126 China: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 127 China: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 128 China: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 129 China: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 130 China: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 131 Japan: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 132 Japan: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 133 Japan: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 134 Japan: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 135 Japan: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 136 Japan: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 137 Japan: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 138 India: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 139 India: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 140 India: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 141 India: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 142 India: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 143 India: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 144 India: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 145 South Korea: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 146 South Korea: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 147 South Korea: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 148 South Korea: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 149 South Korea: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 150 South Korea: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 151 South Korea: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 152 Australia: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 153 Australia: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 154 Australia: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 155 Australia: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 156 Australia: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 157 Australia: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 158 Australia: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 159 Rest of Asia-Pacific: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 160 Rest of Asia-Pacific: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 161 Rest of Asia-Pacific: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 162 Rest of Asia-Pacific: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 163 Rest of Asia-Pacific: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 164 Rest of Asia-Pacific: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 165 Rest of Asia-Pacific: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 166 Latin America: Autoinjectors Market, by Country/Region, 2022–2031 (USD Million)
Table 167 Latin America: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 168 Latin America: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 169 Latin America: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 170 Latin America: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 171 Latin America: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 172 Latin America: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 173 Latin America: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 174 Brazil: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 175 Brazil: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 176 Brazil: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 177 Brazil: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 178 Brazil: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 179 Brazil: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 180 Brazil: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 181 Mexico: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 182 Mexico: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 183 Mexico: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 184 Mexico: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 185 Mexico: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 186 Mexico: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 187 Mexico: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 188 Rest of Latin America: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 189 Rest of Latin America: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 190 Rest of Latin America: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 191 Rest of Latin America: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 192 Rest of Latin America: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 193 Rest of Latin America: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 194 Rest of Latin America: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 195 Middle East & Africa: Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 196 Middle East & Africa: Smart Autoinjectors Market, by Type, 2022–2031 (USD Million)
Table 197 Middle East & Africa: Autoinjectors Market, by Route of Administration, 2022–2031 (USD Million)
Table 198 Middle East & Africa: Autoinjectors Market, by Technology, 2022–2031 (USD Million)
Table 199 Middle East & Africa: Autoinjectors Market, by Application, 2022–2031 (USD Million)
Table 200 Middle East & Africa: Autoinjectors Market, by Distribution Channel, 2022–2031 (USD Million)
Table 201 Middle East & Africa: Autoinjectors Market, by End User, 2022–2031 (USD Million)
Table 202 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Autoinjectors Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 8 Global Autoinjectors Market, by Route of Administration, 2024 Vs. 2031 (USD Million)
Figure 9 Global Autoinjectors Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 10 Global Autoinjectors Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 11 Global Autoinjectors Market, by Distribution Channel, 2024 Vs. 2031 (USD Million)
Figure 12 Global Autoinjectors Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 13 Global Autoinjectors Market, by Geography
Figure 14 Impact Analysis: Autoinjectors Market
Figure 15 Global Autoinjectors Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 16 Global Autoinjectors Market, by Route of Administration, 2024 Vs. 2031 (USD Million)
Figure 17 Global Autoinjectors Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 18 Global Autoinjectors Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 19 Global Autoinjectors Market, by Distribution Channel, 2024 Vs. 2031 (USD Million)
Figure 20 Global Autoinjectors Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 21 Global Autoinjectors Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 22 North America: Autoinjectors Market Snapshot
Figure 23 Europe: Autoinjectors Market Snapshot
Figure 24 Asia-Pacific: Autoinjectors Market Snapshot
Figure 25 Latin America: Autoinjectors Market Snapshot
Figure 26 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 27 Global Autoinjectors Market: Competitive Benchmarking, by Type
Figure 28 Global Autoinjectors Market: Competitive Benchmarking, by Geography
Figure 29 Global Autoinjectors Market: Competitive Dashboard
Figure 30 Global Autoinjectors Market: Market Share Analysis/Market Rankings of Key Players (2023)
Figure 31 Becton, Dickinson and Company: Financial Overview (2023)
Figure 32 Ypsomed AG: Financial Overview (2023)
Figure 33 Recipharm AB: Financial Overview (2023)
Figure 34 Halozyme, Inc.: Financial Overview (2023)
Figure 35 AstraZeneca: Financial Overview (2023)
Figure 36 Teva Pharmaceutical Industries Ltd.: Financial Overview (2023)
Figure 37 Solteam Incorporation Co., Ltd: Financial Overview (2022)
Figure 38 Gerresheimer AG: Financial Overview (2023)
Figure 39 West Pharmaceutical Services, Inc.: Financial Overview (2023)
Figure 40 Bayer AG: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Pharmaceutical Packaging Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Apr-2024
Drug Delivery Devices Market - Global Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Aug-2024
Psoriasis Treatment Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jun-2024
